ACVRL1 and hereditary hemorrhagic telangiectasia: Additionally, the discovery rate for a causal or possibly causative pathogenic variant in an exon or intron/exon border of ENG, ACVRL1, or SMAD4 is 97% for patients who meet the Curaçao diagnostic criteria for HHT.6